All proposed resolutions at the Annual General Meeting of June 28, 2012 were voted according to management’s recommendations

Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces that its Annual General Meeting (“AGM”) took place on June 28, 2012, in Marseilles, France.
A number of 21,148,778 votes were expressed out of a total of 37,558,711 shares with voting rights, representing a quorum of 56.3%. All resolutions were voted in accordance with the management’s recommendations.